$HCA Healthcare (HCA.US)$ 🎯 2024.4.10 Current price 327.09,...

New data: 23Q3 and 23Q4. Revenue increased continuously. Operating profit contracted for a while in Q3 due to cost increases, growth resumed in Q4, and net profit shrank continuously due to interest expenses.

In 2023, revenue increased 7.9%, and operating profit increased 6.3%, basically returning to 2021 levels. Net profit shrank 10.9% due to lack of revenue from business sales. In fact, net profit for 2021 and 2022 was inflated due to business sales. The average net profit growth rate in the past 3 years was 11.6%.

The balance ratio fell from 100.1% to 98.1%. Net assets were finally corrected, cash increased slightly, and accounts receivable increased to 9.96 billion yuan. The ratio was quite normal, and short-term debt-side loans increased a lot.

The net operating cash flow is higher than the net investment amount, generating a certain shareholders' surplus.

Currently, the price-earnings ratio is 17.3. The valuation is still within a reasonable range, and no adjustments will be made for the time being.